NCT06603220Phase 2Completed

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Study sponsor: Evommune, Inc. · EVMN

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-08Actual
Enrollment · participants30Actual
Source updated2026-05-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Safety and tolerability. After: Measure: Safety and Tolerability.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview